FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

29937711000001107: Bramox 5mg tablets (Brancaster Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Aug 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93574101000001119 Bramox 5mg tablets (Brancaster Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93574201000001114 Bramox 5mg tablets (Brancaster Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bramox 5mg tablets (Brancaster Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Is a Product containing precisely midodrine hydrochloride 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has active ingredient Midodrine hydrochloride false Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has specific active ingredient Midodrine hydrochloride true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) Is a Bramox true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bramox 5mg tablets (Brancaster Pharma Ltd) 100 tablet Has AMP True Bramox 5mg tablets (Brancaster Pharma Ltd) Inferred relationship Existential restriction modifier
Bramox 5mg tablets (Brancaster Pharma Ltd) 100 tablet 10 x 10 tablets Has AMP True Bramox 5mg tablets (Brancaster Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start